BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37221653)

  • 21. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
    Perkins RB; Guido RS; Castle PE; Chelmow D; Einstein MH; Garcia F; Huh WK; Kim JJ; Moscicki AB; Nayar R; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M;
    J Low Genit Tract Dis; 2020 Apr; 24(2):102-131. PubMed ID: 32243307
    [No Abstract]   [Full Text] [Related]  

  • 22. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States.
    Irwin K; Montaño D; Kasprzyk D; Carlin L; Freeman C; Barnes R; Jain N; Christian J; Wolters C
    Obstet Gynecol; 2006 Aug; 108(2):397-409. PubMed ID: 16880312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.
    Saslow D; Solomon D; Lawson HW; Killackey M; Kulasingam SL; Cain J; Garcia FA; Moriarty AT; Waxman AG; Wilbur DC; Wentzensen N; Downs LS; Spitzer M; Moscicki AB; Franco EL; Stoler MH; Schiffman M; Castle PE; Myers ER; ; ;
    Am J Clin Pathol; 2012 Apr; 137(4):516-42. PubMed ID: 22431528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists.
    Perkins RB; Anderson BL; Gorin SS; Schulkin JA
    Am J Prev Med; 2013 Aug; 45(2):175-81. PubMed ID: 23867024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No. 385-Indications for Pelvic Examination.
    Evans D; Goldstein S; Loewy A; Altman AD
    J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice.
    Wentzensen N; Schiffman M; Silver MI; Khan MJ; Perkins RB; Smith KM; Gage JC; Gold MA; Conageski C; Einstein MH; Mayeaux EJ; Waxman AG; Huh WK; Massad LS
    J Low Genit Tract Dis; 2017 Oct; 21(4):230-234. PubMed ID: 28953111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of Cervical Cancer Screening Patterns Among Women With Systemic Lupus Erythematosus.
    Chung SH; Oshima K; Singleton M; Thomason J; Currier C; McCartney S; Singh N
    J Rheumatol; 2022 Nov; 49(11):1236-1241. PubMed ID: 35970535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Would Women With Solid Organ Transplant Qualify for Triennial Cervical Cancer Screening as Recommended by the American College of Obstetricians and Gynecologists in 2016 and American Society for Colposcopy and Cervical Pathology in 2019?
    Long ME; Chantigian PDM; Weaver AL
    J Low Genit Tract Dis; 2021 Apr; 25(2):92-97. PubMed ID: 33631778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An assessment of gynecological cytology screening practices among health care providers nationwide.
    Darwish-Yassine M; Garvin AD; Johnston CM; Zoschnick L; Conners A; Laing S; Wojcik C
    Arch Pathol Lab Med; 2015 May; 139(5):650-5. PubMed ID: 25927148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple clinical practice guidelines for breast and cervical cancer screening: perceptions of US primary care physicians.
    Han PK; Klabunde CN; Breen N; Yuan G; Grauman A; Davis WW; Taplin SH
    Med Care; 2011 Feb; 49(2):139-48. PubMed ID: 21206294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary care physicians' awareness and adherence to cervical cancer screening guidelines in Texas.
    Holland-Barkis P; Forjuoh SN; Couchman GR; Capen C; Rascoe TG; Reis MD
    Prev Med; 2006 Feb; 42(2):140-5. PubMed ID: 16290022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 2006 consensus guidelines for the management of women with abnormal cervical screening tests: challenges remain.
    Colgan TJ
    Cancer Cytopathol; 2010 Oct; 118(5):233-7. PubMed ID: 20629030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are the University Hospitals in Puerto Rico following Current Guidelines for Cervical Cancer Screening?
    Méndez K; Rodríguez N; Sánchez I; Lozada Y; Piñero I; Donate D; Romaguera J
    P R Health Sci J; 2015 Sep; 34(3):142-7. PubMed ID: 26356738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating Stakeholder Feedback in Guidelines Development for the Management of Abnormal Cervical Cancer Screening Tests.
    Perkins RB; Fuzzell LN; Lake P; McIntyre M; Nayar R; Saraiya M; Loukissas J; Felder T; Guido RS; Vadaparampil ST
    J Low Genit Tract Dis; 2020 Apr; 24(2):167-177. PubMed ID: 32243312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
    Massad LS; Einstein MH; Huh WK; Katki HA; Kinney WK; Schiffman M; Solomon D; Wentzensen N; Lawson HW;
    Obstet Gynecol; 2013 Apr; 121(4):829-846. PubMed ID: 23635684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
    Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
    CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.
    Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Whitmer A; Michel A; McIntyre M; Rossi SL; Kajtezovic S; Vadaparampil ST; Perkins R
    Elife; 2023 Sep; 12():. PubMed ID: 37664989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Summary of Current Guidelines for Cervical Cancer Screening and Management of Abnormal Test Results: 2016-2020.
    Perkins RB; Guido RL; Saraiya M; Sawaya GF; Wentzensen N; Schiffman M; Feldman S
    J Womens Health (Larchmt); 2021 Jan; 30(1):5-13. PubMed ID: 33464997
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.